Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matthew Steven Davids, M.D.

Concepts (430)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Matthew Davids's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Matthew Davids has written about over time.
Pyrimidines, 23 publications between 2009 and 2023, average publication date September 2017. Quinazolinones, 8 publications between 2012 and 2021, average publication date September 2017. Pyrazoles, 18 publications between 2014 and 2021, average publication date October 2017. Protein Kinase Inhibitors, 23 publications between 2009 and 2023, average publication date January 2018. Proto-Oncogene Proteins c-bcl-2, 31 publications between 2012 and 2024, average publication date February 2018. Hematologic Neoplasms, 10 publications between 2010 and 2023, average publication date March 2018. Sulfonamides, 41 publications between 2009 and 2024, average publication date May 2018. Adenine, 20 publications between 2014 and 2024, average publication date June 2018. Purines, 12 publications between 2012 and 2021, average publication date August 2018. Antineoplastic Agents, 39 publications between 2012 and 2024, average publication date September 2018. Piperidines, 22 publications between 2014 and 2024, average publication date November 2018. Antineoplastic Combined Chemotherapy Protocols, 42 publications between 2012 and 2023, average publication date March 2019. Lymphoma, Non-Hodgkin, 6 publications between 2014 and 2023, average publication date April 2019. Leukemia, Lymphocytic, Chronic, B-Cell, 100 publications between 2012 and 2024, average publication date May 2019. Benzamides, 7 publications between 2014 and 2021, average publication date June 2019. Lymphoma, Mantle-Cell, 8 publications between 2016 and 2021, average publication date January 2020. Vidarabine, 5 publications between 2017 and 2024, average publication date August 2020. Lymphoma, Large B-Cell, Diffuse, 13 publications between 2012 and 2024, average publication date November 2020. Lymphoma, B-Cell, Marginal Zone, 3 publications between 2021 and 2021, average publication date June 2021.

To see the data from this visualization as text, click here.
Davids's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (430)
Explore
_
Co-Authors (158)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.